To assess the association between inclusion of a macrolide in a β-lactam—based empirical
antibiotic regimen and mortality among patients with bacteremic pneumococcal pneumonia …

A cohort of 1,391 patients with community-acquired pneumonia of unknown etiology,
atypical pneumonia, Legionella pneumophila pneumonia, viral pneumonia, or …

To determine the impact of initial antimicrobial choice on 30-day mortality rate in patients
with community-acquired pneumonia due to Streptococcus pneumoniae (CAP-SP), a …

Background Although monotherapy for pneumococcal pneumonia is standard, a survival
benefit of combination β-lactam and macrolide therapy has been suggested. Hypothesis …

Background: The questions of whether the use of antibiotics that are active against atypical
organisms is beneficial in the treatment of community-acquired pneumonia and of the …

Retrospective studies have suggested that combination antibiotic therapy for severe
bacteremic pneumococcal pneumonia may reduce mortality. We assessed this issue in a …

Study objectives: To examine the association of empiric inpatient antibiotic treatment of
community-acquired pneumonia (CAP) with mortality, and whether this association varies …

BACKGROUND: Approximately 10% of patients hospitalized with community‐acquired
pneumonia (CAP) are bacteremic. Bacteremic Streptococcus pneumoniae pneumonia …

Prospective observational study of bacteremic pneumococcal p... : Critical Care Medicine
Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant …

Importance Antibiotic therapy is the cornerstone of medical management for community-
acquired pneumonia. Objective To assess the associations between 3 key aspects of …